Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (6803)	2/19/2000 10:23:00 PM
From: Mike M	Respond to of 10293

Hey, Bill. Why don't you answer my questions yourself? Do you always send the lemmings out in the field when the going gets tough? Bill doesn't have any answers. Hell, he doesn't even know what the questions are.

To: DanZ who wrote (6803)	2/20/2000 10:18:00 PM
From: Hank	Respond to of 10293

"I don't give a damn if Bill or anyone agrees with me about a stock." Then why do you continue to post your BS on this thread? "You stated opinions in your post as if they are facts." I think most people here are intelligent enough to distinguish opinion from fact, present company excepted. I don't need to post a disclaimer every time I voice an opinion. What about you Danny? You make grandiose predictions about what GUMM will achieve in the next year based on ONE measly profitable quarter. Is this not posting opinion as though it were fact? Oh, that's right. I'm talking to Dan "Svengali" Zimmerman. "Yet, we are to believe your comment "Studies on Zicam are statistically insignificant, hence they will NEVER be published in a major medical journal such as NEJM"?" That's correct. Zicam studies will NEVER be published in a highly respected top notch journal like NEJM. That's why they had to shoot for a third rate journal like AJIC and they even screwed that one up. "According to the FTC, Zicam is proven..." The result of just one of many legal loop holes. Not every branch of government operates at 100% efficiency and that just proves it. The FTC needs to revamp their rules and regulations regarding homeopathic products like Zicam. Unfortunately, the real losers are the consumers that get duped into buying those products. "You mean to tell me that a half dozen companies will go to the trouble and expense of doing the R&D, development,..." What R&D and development? It's frigging ZINC you moron. How many of the Cold-Eezz knock offs do you think went through an elaborate R&D development process? Whether it works or not isn't the question. The question is, are there enough gullible people out there that believe Zinc will cure their colds to sell these products to? Obviously, the answer is yes since even my local super market has it's own generic version of cold-eez on it's shelves. There will always be a small percentage of the consumer base that will buy these products but you'll never see the day when the majority of people run to a store to buy Zicam,or anything similar, as soon as they feel a cold coming on. It doesn't cost a hell of a lot to put some zinc solution in a squeeze bottle and throw it out there with Zicam. The marketing and development cost would be minimal. If it makes a few bucks, they will do it. "You say there are a dozen products on the market. List them. You are lying." No. You are lying Danny. Do you ever read the paper? I constantly see ads for remedies to help people quit smoking. Some are pills. Some are self hypnosis. Then you have Nicorette, Nicoderm patches, Zyban, those mechanical filter devices that supposedly remove most of the nicotine from cigarette smoke and many more that I can't remember off hand. All of which have been on the market for awhile now. In fact, I'm listening to a commercial for Nicoderm CQ as I write this. I'm sure GUMM's crummy nicotine gum will just blow products like these right out of existence. LOL!!!!!!! Sure, GUMM will sell a few sticks of it's gum but you imply they will take over the entire $500 million dollar nicotine gum market. You're real funny. Their market share won't amount to squat. Do you think a lousy 10 million dollars is enough to compete with some of the companies you've mentioned such as Novartis? They are a 20+ billion dollar a year company and eat companies like GUMM for lunch! "Gum Tech is developing other products that they aren't talking about." If that's so, then how is it that YOU seem to know about them? Oh, that's right. Svengali. You're a joke Danny.